Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of chronic diseases, surging use of infusion therapy devices in home care settings, and growing demand for parenteral nutrition.
The infusion therapy devices market is segmented as below:
By End-user
- Hospitals
- Homecare settings
- Clinics and ASCs
By Product
- Infusion pumps
- Consumables
- accessories
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the infusion therapy devices market covers the following areas:
- Infusion therapy devices market sizing
- Infusion therapy devices market forecast
- Infusion therapy devices market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
Executive Summary
The publisher recognizes the following companies as the key players in the global infusion therapy devices market: Ace medical, AngioDynamics Inc., Avanos Medical Inc., B.Braun SE, Baxter International Inc., Becton Dickinson and Company, Canafusion Technologies Inc., Cardinal Health Inc., Chemyx Inc., ERENLER MEDIKAL SAN. TIC. LTD. STI., Fresenius SE and Co. KGaA, ICU Medical Inc., IRadimed Corp., Medtronic, Poly Medicure Ltd., Smith and Nephew plc, Tekni Plex Inc., Teleflex Inc., Terumo Corp., and Vygon SAS.Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is emergence of smart infusion therapy devices.'
According to the report, one of the major drivers for this market is the increasing prevalence of chronic diseases.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Ace medical
- AngioDynamics Inc.
- Avanos Medical Inc.
- B.Braun SE
- Baxter International Inc.
- Becton Dickinson and Company
- Canafusion Technologies Inc.
- Cardinal Health Inc.
- Chemyx Inc.
- ERENLER MEDIKAL SAN. TIC. LTD. STI.
- Fresenius SE and Co. KGaA
- ICU Medical Inc.
- IRadimed Corp.
- Medtronic
- Poly Medicure Ltd.
- Smith and Nephew plc
- Tekni Plex Inc.
- Teleflex Inc.
- Terumo Corp.
- Vygon SAS